• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human JmjC domain-containing protein 4 (JMJD4)

ACP11255

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP11255 Target NameJMJD4
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-463Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9H9V9
Background Information
  • Uniprot Id

    Q9H9V9

  • Target Species

    Human

  • Target Name

    JMJD4

  • Target Full Name

    2-oxoglutarate and iron-dependent oxygenase JMJD4

  • Target Function

    Catalyzes the 2-oxoglutarate and iron-dependent C4-lysyl hydroxylation of ETF1 at 'Lys-63' thereby promoting the translational termination efficiency of ETF1.

  • Target Subcellular Location

    Cytoplasm.

  • Target Synonyms

    6430559I23; AU020939; JmjC domain containing protein 4; JmjC domain-containing protein 4; JMJD 4; JMJD4; JMJD4_HUMAN; Jumonji domain containing 4; Jumonji domain-containing protein 4; RGD1307186; RP23 210M6.10

  • Target Background

    Enables 2-oxoglutarate-dependent dioxygenase activity. Involved in positive regulation of translational termination and protein hydroxylation. Located in cytoplasm.

Inquire Recombinant Human JmjC domain-containing protein 4 (JMJD4) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification